(Mount Laurel, NJ, October 14, 2022)—Abstracts of breaking research in neurology and neuroscience, to be presented at the , are now available in and open-access on the .
. You can also view the Research Alerts below for some high-impact research highlights:
- PARKINSON’S DISEASE: Uncovering why nicotine may be protective
Abby Olsen, MD, PhD, University of Pittsburgh. “Nicotine-mediated Rescue Of Alpha-synuclein Toxicity Requires Synaptic Vesicle Glycoprotein 2c.” - STROKE: Death rates are decreasing, but race and sex disparities remain
Daniel Oh, MD, University of Southern California. “Trends in Stroke Mortality by Race/Ethnicity and Sex in the U.S. 2000–2019.” - ALZHEIMER’S DISEASE: Making connections between air pollution and neurodegeneration
Hendrik Greve, PhD, Indiana University School of Medicine. “Ozone Air Pollution and Alzheimer’s Disease: An Emerging Role for HMGB1 in the Lung-Brain Axis.” - MOVEMENT DISORDERS: Aerobic exercise may help more than balance training to hold off symptoms of cerebellar ataxia
Scott Barbuto, MD, PhD, Columbia University Medical Center. “Home Aerobic Versus Balance Training In Cerebellar Ataxias.” - MULTIPLE SYSTEM ATROPHY: Identifying cells that accelerate disease progression
Jun-ichi Kira, MD, PhD, International University of Health and Welfare, Fukuoka, Japan. “Synucleionopathy-Associated Microglia Uncovered by a Novel Multiple System Atrophy-Cerebellar Type (MSA-c) Mouse Model.” - VERTIGO: Remote diagnosis by experts using video-oculography can help rule out benign causes of dizziness and vertigo
Shervin Badihian, MD, Johns Hopkins University School of Medicine. “Remote Expert Diagnosis by Video-Oculography is More Accurate Than In-Person ED Diagnosis in Acute Vertigo and Dizziness—Preliminary Results of the AVERT Trial.”
About ANA2022
The , taking place October 22–25 at the Hyatt Regency Chicago, features hundreds of presentations on breaking research from academic neurologists and neuroscientists nationwide. This year’s groundbreaking research includes demonstrated links between environmental exposures and Alzheimer’s disease, disparities in stroke deaths, why nicotine may reduce Parkinson’s risk, and cardio training as therapy for movement disorders. .
The ANA Annual Meeting convenes the top academic neurologists in the United States, international neurology leaders, trainees, and students around key developments in neurology and neuroscience. Plenary sessions will focus on issues including environmental exposures and neurologic disease, equity and disparities in neurology, and pathologic interactions between the nervous system and other organ systems. Members of the media are welcome to attend the full meeting ( and the ). You can .
The meeting will feature a “Highlights of the Meeting” media roundtable on Tuesday, October 25, 2022 from 11:00 am to 12:00 p.m. (U.S. Central Time), during which the chairs of the principal symposia will present highlights, discuss the relevance of the work, and answer questions.
About the American Neurological Association (ANA)
From advances in stroke and dementia to movement disorders and epilepsy, the has been the vanguard of research since 1875 as the premier professional society of academic neurologists and neuroscientists devoted to understanding and treating diseases of the nervous system. Its monthly Annals of Neurology is among the world’s most prestigious medical journals, and the ANA’s Annals of Clinical and Translational Neurology is an online-only, open access journal providing rapid dissemination of high-quality, peer-reviewed research related to all areas of neurology. The acclaimed draws faculty and trainees from the top academic departments across the U.S. and abroad for groundbreaking research, networking, and career development. For more information, visit or @TheNewANA1.